These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

201 related items for PubMed ID: 8882028

  • 1. The frequency of cutaneous vasculitis is not increased in patients with rheumatoid arthritis treated with methotrexate.
    Kaye O, Beckers CC, Paquet P, Arrese JE, Piérard GE, Malaise MG.
    J Rheumatol; 1996 Feb; 23(2):253-7. PubMed ID: 8882028
    [Abstract] [Full Text] [Related]

  • 2. Longterm combination therapy of refractory and destructive rheumatoid arthritis with methotrexate (MTX) and intramuscular gold or other disease modifying antirheumatic drugs compared to MTX monotherapy.
    Rau R, Schleusser B, Herborn G, Karger T.
    J Rheumatol; 1998 Aug; 25(8):1485-92. PubMed ID: 9712088
    [Abstract] [Full Text] [Related]

  • 3. Pretreatment cytokine profiles of peripheral blood mononuclear cells and serum from patients with rheumatoid arthritis in different american college of rheumatology response groups to methotrexate.
    Seitz M, Zwicker M, Villiger PM.
    J Rheumatol; 2003 Jan; 30(1):28-35. PubMed ID: 12508386
    [Abstract] [Full Text] [Related]

  • 4. Treatment of early rheumatoid arthritis: a randomized magnetic resonance imaging study comparing the effects of methotrexate alone, methotrexate in combination with infliximab, and methotrexate in combination with intravenous pulse methylprednisolone.
    Durez P, Malghem J, Nzeusseu Toukap A, Depresseux G, Lauwerys BR, Westhovens R, Luyten FP, Corluy L, Houssiau FA, Verschueren P.
    Arthritis Rheum; 2007 Dec; 56(12):3919-27. PubMed ID: 18050189
    [Abstract] [Full Text] [Related]

  • 5. Reduction of the efficacy of methotrexate by the use of folic acid: post hoc analysis from two randomized controlled studies.
    Khanna D, Park GS, Paulus HE, Simpson KM, Elashoff D, Cohen SB, Emery P, Dorrier C, Furst DE.
    Arthritis Rheum; 2005 Oct; 52(10):3030-8. PubMed ID: 16200612
    [Abstract] [Full Text] [Related]

  • 6. Dietary caffeine intake does not affect methotrexate efficacy in patients with rheumatoid arthritis.
    Benito-Garcia E, Heller JE, Chibnik LB, Maher NE, Matthews HM, Bilics JA, Weinblatt ME, Shadick NA.
    J Rheumatol; 2006 Jul; 33(7):1275-81. PubMed ID: 16821266
    [Abstract] [Full Text] [Related]

  • 7. Determinants of red blood cell methotrexate polyglutamate concentrations in rheumatoid arthritis patients receiving long-term methotrexate treatment.
    Stamp LK, O'Donnell JL, Chapman PT, Zhang M, Frampton C, James J, Barclay ML.
    Arthritis Rheum; 2009 Aug; 60(8):2248-56. PubMed ID: 19644853
    [Abstract] [Full Text] [Related]

  • 8. Methotrexate reduces incidence of vascular diseases in veterans with psoriasis or rheumatoid arthritis.
    Prodanovich S, Ma F, Taylor JR, Pezon C, Fasihi T, Kirsner RS.
    J Am Acad Dermatol; 2005 Feb; 52(2):262-7. PubMed ID: 15692471
    [Abstract] [Full Text] [Related]

  • 9. 2756GG genotype of methionine synthase reductase gene is more prevalent in rheumatoid arthritis patients treated with methotrexate and is associated with methotrexate-induced nodulosis.
    Berkun Y, Abou Atta I, Rubinow A, Orbach H, Levartovsky D, Aamar S, Arbel O, Dresner-Pollak R, Friedman G, Ben-Yehuda A.
    J Rheumatol; 2007 Aug; 34(8):1664-9. PubMed ID: 17611986
    [Abstract] [Full Text] [Related]

  • 10. Treatment of early seropositive rheumatoid arthritis: doxycycline plus methotrexate versus methotrexate alone.
    O'Dell JR, Elliott JR, Mallek JA, Mikuls TR, Weaver CA, Glickstein S, Blakely KM, Hausch R, Leff RD.
    Arthritis Rheum; 2006 Feb; 54(2):621-7. PubMed ID: 16447240
    [Abstract] [Full Text] [Related]

  • 11. Influence of methotrexate, TNF blockers and prednisolone on antibody responses to pneumococcal polysaccharide vaccine in patients with rheumatoid arthritis.
    Kapetanovic MC, Saxne T, Sjöholm A, Truedsson L, Jönsson G, Geborek P.
    Rheumatology (Oxford); 2006 Jan; 45(1):106-11. PubMed ID: 16287919
    [Abstract] [Full Text] [Related]

  • 12. Influence of methotrexate on the frequency of postoperative infectious complications in patients with rheumatoid arthritis.
    Sany J, Anaya JM, Canovas F, Combe B, Jorgensen C, Saker S, Thaury MN, Gavroy JP.
    J Rheumatol; 1993 Jul; 20(7):1129-32. PubMed ID: 8371204
    [Abstract] [Full Text] [Related]

  • 13. Lymphoproliferative disorders in rheumatoid arthritis: clinicopathological analysis of 76 cases in relation to methotrexate medication.
    Hoshida Y, Xu JX, Fujita S, Nakamichi I, Ikeda J, Tomita Y, Nakatsuka S, Tamaru J, Iizuka A, Takeuchi T, Aozasa K.
    J Rheumatol; 2007 Feb; 34(2):322-31. PubMed ID: 17117491
    [Abstract] [Full Text] [Related]

  • 14. Two-year, blinded, randomized, controlled trial of treatment of active rheumatoid arthritis with leflunomide compared with methotrexate. Utilization of Leflunomide in the Treatment of Rheumatoid Arthritis Trial Investigator Group.
    Cohen S, Cannon GW, Schiff M, Weaver A, Fox R, Olsen N, Furst D, Sharp J, Moreland L, Caldwell J, Kaine J, Strand V.
    Arthritis Rheum; 2001 Sep; 44(9):1984-92. PubMed ID: 11592358
    [Abstract] [Full Text] [Related]

  • 15. A cost-effectiveness analysis of treatment options for patients with methotrexate-resistant rheumatoid arthritis.
    Choi HK, Seeger JD, Kuntz KM.
    Arthritis Rheum; 2000 Oct; 43(10):2316-27. PubMed ID: 11037892
    [Abstract] [Full Text] [Related]

  • 16. Contemporary disease modifying antirheumatic drugs (DMARD) in patients with recent onset rheumatoid arthritis in a US private practice: methotrexate as the anchor drug in 90% and new DMARD in 30% of patients.
    Sokka T, Pincus T.
    J Rheumatol; 2002 Dec; 29(12):2521-4. PubMed ID: 12465145
    [Abstract] [Full Text] [Related]

  • 17. IgG and IgM anticardiolipin antibodies following treatment with infliximab plus methotrexate in patients with early rheumatoid arthritis.
    Visvanathan S, Wagner C, Smolen J, St Clair EW, Hegedus R, Baker D, Keenan G.
    Arthritis Rheum; 2006 Sep; 54(9):2840-4. PubMed ID: 16948115
    [Abstract] [Full Text] [Related]

  • 18. Dose escalation of parenteral methotrexate in active rheumatoid arthritis that has been unresponsive to conventional doses of methotrexate: a randomized, controlled trial.
    Lambert CM, Sandhu S, Lochhead A, Hurst NP, McRorie E, Dhillon V.
    Arthritis Rheum; 2004 Feb; 50(2):364-71. PubMed ID: 14872477
    [Abstract] [Full Text] [Related]

  • 19. Epstein-Barr virus, methotrexate, and lymphoma in patients with rheumatoid arthritis and primary Sjögren's syndrome: case series.
    Dawson TM, Starkebaum G, Wood BL, Willkens RF, Gown AM.
    J Rheumatol; 2001 Jan; 28(1):47-53. PubMed ID: 11196542
    [Abstract] [Full Text] [Related]

  • 20. Response to pneumococcal vaccine in patients with early rheumatoid arthritis receiving infliximab plus methotrexate or methotrexate alone.
    Visvanathan S, Keenan GF, Baker DG, Levinson AI, Wagner CL.
    J Rheumatol; 2007 May; 34(5):952-7. PubMed ID: 17444589
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.